KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Research & Development (2016 - 2025)

Historic Research & Development for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $346.0 million.

  • Thermo Fisher Scientific's Research & Development changed 0.0% to $346.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 528.67%. This contributed to the annual value of $1.4 billion for FY2024, which is 396.41% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Research & Development is $346.0 million, which was down 0.0% from $352.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Research & Development ranged from a high of $392.0 million in Q4 2021 and a low of $319.0 million during Q3 2023
  • Over the past 5 years, Thermo Fisher Scientific's median Research & Development value was $346.0 million (recorded in 2023), while the average stood at $349.7 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 3061.22% in 2021, then plummeted by 1636.83% in 2023.
  • Thermo Fisher Scientific's Research & Development (Quarter) stood at $392.0 million in 2021, then decreased by 0.26% to $391.0 million in 2022, then decreased by 16.37% to $327.0 million in 2023, then grew by 14.37% to $374.0 million in 2024, then fell by 7.49% to $346.0 million in 2025.
  • Its Research & Development stands at $346.0 million for Q3 2025, versus $352.0 million for Q2 2025 and $342.0 million for Q1 2025.